Rituximab, Lenalidomide, Acalabrutinib, Tafasitamab Alone and With Combination Chemotherapy for the Treatment of Newly Diagnosed Non-germinal Center Diffuse Large B-Cell Lymphoma, Smart Stop Study

Condition:   Diffuse Large B-Cell Lymphoma Interventions:   Drug: Acalabrutinib;   Drug: Cyclophosphamide;   Drug: Doxorubicin Hydrochloride;   Drug: Lenalidomide;   Drug: Prednisone;   Biological: Rituximab;   Biological: Tafasitamab;   Drug: Vincristine Sponsor:   M.D. Anderson Cancer Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials